Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Family History Only

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Family History Only1
  • Family History Whole Genome Sequencing1

Active Sponsors

  • National Human Genome Research Institute (NHGRI)1
  • Duke University1
  • Brigham and Women's Hospital1
  • Baylor College of Medicine1

Top Investigators

Related Conditions

  • Healthy Adults Full Study And Extension Phase1

Activity Timeline